NG-094

NG-094 is an experimental small molecule drug candidate being developed by N-Gene Research Laboratories. It is designed as a heat shock protein (HSP) modulator for the treatment of nervous system diseases. Based on N-Gene's proprietary technology platform, NG-094 likely functions as an HSP co-inducer, a class of compounds that do not induce heat shock proteins by themselves but enhance their expression in response to existing cellular stress. This mechanism is intended to provide neuroprotection by improving protein folding and preventing the aggregation of toxic proteins, which are hallmark features of many neurodegenerative disorders. The drug is currently in the early stages of development.